Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Rivian Automotive, Inc. (RIVN) vs Twist Bioscience Corp (TWST) Price & Performance

Rivian Automotive, Inc.Trade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Rivian Automotive, Inc. vs Twist Bioscience Corp — how do they compare? Rivian Automotive, Inc. trades at $17.14 (market cap $25.71B), while Twist Bioscience Corp trades at $93.82 (market cap $5.97B). The key difference: Rivian Automotive, Inc. is far larger — about 4.3× Twist Bioscience Corp's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Rivian Automotive, Inc. nearer its low. Which is the better fit depends on your goals.

RIVNTWST
Market Cap
$25.71B$5.97B
Sector
Consumer CyclicalHealth
52-Week High
$22.45$102.88
52-Week Low
$11.64$24.16
Enterprise Value
$27.45B$5.89B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Rivian Automotive, Inc.

No Aura AI signal available yet.

Twist Bioscience Corp

TWST trades at $95.86, up 2.14% today, with a bullish technical signal and strong institutional interest. Revenue growth is robust, rising from $204M in 2022 to $377M in 2025, though the company remains unprofitable with a net income margin of -19.85%. Recent news highlights AI-driven collaborations and earnings beats, but cash flow trends show persistent operational losses.

The outlook is mixed; analyst consensus is bullish with a $91.63 price target, but profitability challenges and negative cash flows pose significant risks. Investment opportunity lies in continued revenue expansion and AI partnerships, while execution risks and high valuations require caution.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Rivian Automotive, Inc.

Rivian Automotive, Inc. is an automotive technology company. The Company designs and manufactures vans, trucks, and sports utility vehicles, as well as offers repair and maintenance services. Rivian Automotive serves customers in North America and the United Kingdom.

Read more on RIVN

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST